You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Investing in the life science sector
Analyst Interviews
Life science analyst Antti Siltanen reveals some truths about investing in life science companies. Learn about the biggest misconceptions about life science companies, what to consider when evaluating the potential of a new drug, and the trends shaping the life sciences landscape in the next 5-10 years. Antti also provides some advice for investors looking to get started in life science investing.